366 related articles for article (PubMed ID: 32454036)
1. ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
Vilar-Gomez E; Sookoian S; Pirola CJ; Liang T; Gawrieh S; Cummings O; Liu W; Chalasani NP
Gastroenterology; 2020 Sep; 159(3):929-943. PubMed ID: 32454036
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease.
Sookoian S; Flichman D; Castaño GO; Pirola CJ
Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1224-1234. PubMed ID: 27778410
[TBL] [Abstract][Full Text] [Related]
3. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.
Ajmera V; Belt P; Wilson LA; Gill RM; Loomba R; Kleiner DE; Neuschwander-Tetri BA; Terrault N;
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1511-1520.e5. PubMed ID: 29378307
[TBL] [Abstract][Full Text] [Related]
4. Alcohol dehydrogenase-1B genotype (rs1229984) is a strong determinant of the relationship between body weight and alcohol intake in Japanese alcoholic men.
Yokoyama A; Yokoyama T; Matsui T; Mizukami T; Matsushita S; Higuchi S; Maruyama K
Alcohol Clin Exp Res; 2013 Jul; 37(7):1123-32. PubMed ID: 23414439
[TBL] [Abstract][Full Text] [Related]
5. High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.
Xanthakos SA; Jenkins TM; Kleiner DE; Boyce TW; Mourya R; Karns R; Brandt ML; Harmon CM; Helmrath MA; Michalsky MP; Courcoulas AP; Zeller MH; Inge TH;
Gastroenterology; 2015 Sep; 149(3):623-34.e8. PubMed ID: 26026390
[TBL] [Abstract][Full Text] [Related]
6. Alcohol dehydrogenase and aldehyde dehydrogenase gene polymorphisms, alcohol intake and the risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study.
Ferrari P; McKay JD; Jenab M; Brennan P; Canzian F; Vogel U; Tjønneland A; Overvad K; Tolstrup JS; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Kaaks R; Boeing H; Bergmann M; Trichopoulou A; Katsoulis M; Trichopoulos D; Krogh V; Panico S; Sacerdote C; Palli D; Tumino R; Peeters PH; van Gils CH; Bueno-de-Mesquita B; Vrieling A; Lund E; Hjartåker A; Agudo A; Suarez LR; Arriola L; Chirlaque MD; Ardanaz E; Sánchez MJ; Manjer J; Lindkvist B; Hallmans G; Palmqvist R; Allen N; Key T; Khaw KT; Slimani N; Rinaldi S; Romieu I; Boffetta P; Romaguera D; Norat T; Riboli E
Eur J Clin Nutr; 2012 Dec; 66(12):1303-8. PubMed ID: 23149980
[TBL] [Abstract][Full Text] [Related]
7. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).
Dunn W; Sanyal AJ; Brunt EM; Unalp-Arida A; Donohue M; McCullough AJ; Schwimmer JB
J Hepatol; 2012 Aug; 57(2):384-91. PubMed ID: 22521357
[TBL] [Abstract][Full Text] [Related]
8. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
VanWagner LB; Ning H; Allen NB; Ajmera V; Lewis CE; Carr JJ; Lloyd-Jones DM; Terrault NA; Siddique J
Gastroenterology; 2017 Nov; 153(5):1260-1272.e3. PubMed ID: 28802566
[TBL] [Abstract][Full Text] [Related]
9. Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall HU; Hultcrantz R; Stål P
Scand J Gastroenterol; 2017 Feb; 52(2):159-165. PubMed ID: 27650916
[TBL] [Abstract][Full Text] [Related]
10. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data.
Holmes MV; Dale CE; Zuccolo L; Silverwood RJ; Guo Y; Ye Z; Prieto-Merino D; Dehghan A; Trompet S; Wong A; Cavadino A; Drogan D; Padmanabhan S; Li S; Yesupriya A; Leusink M; Sundstrom J; Hubacek JA; Pikhart H; Swerdlow DI; Panayiotou AG; Borinskaya SA; Finan C; Shah S; Kuchenbaecker KB; Shah T; Engmann J; Folkersen L; Eriksson P; Ricceri F; Melander O; Sacerdote C; Gamble DM; Rayaprolu S; Ross OA; McLachlan S; Vikhireva O; Sluijs I; Scott RA; Adamkova V; Flicker L; Bockxmeer FM; Power C; Marques-Vidal P; Meade T; Marmot MG; Ferro JM; Paulos-Pinheiro S; Humphries SE; Talmud PJ; Mateo Leach I; Verweij N; Linneberg A; Skaaby T; Doevendans PA; Cramer MJ; van der Harst P; Klungel OH; Dowling NF; Dominiczak AF; Kumari M; Nicolaides AN; Weikert C; Boeing H; Ebrahim S; Gaunt TR; Price JF; Lannfelt L; Peasey A; Kubinova R; Pajak A; Malyutina S; Voevoda MI; Tamosiunas A; Maitland-van der Zee AH; Norman PE; Hankey GJ; Bergmann MM; Hofman A; Franco OH; Cooper J; Palmen J; Spiering W; de Jong PA; Kuh D; Hardy R; Uitterlinden AG; Ikram MA; Ford I; Hyppönen E; Almeida OP; Wareham NJ; Khaw KT; Hamsten A; Husemoen LL; Tjønneland A; Tolstrup JS; Rimm E; Beulens JW; Verschuren WM; Onland-Moret NC; Hofker MH; Wannamethee SG; Whincup PH; Morris R; Vicente AM; Watkins H; Farrall M; Jukema JW; Meschia J; Cupples LA; Sharp SJ; Fornage M; Kooperberg C; LaCroix AZ; Dai JY; Lanktree MB; Siscovick DS; Jorgenson E; Spring B; Coresh J; Li YR; Buxbaum SG; Schreiner PJ; Ellison RC; Tsai MY; Patel SR; Redline S; Johnson AD; Hoogeveen RC; Hakonarson H; Rotter JI; Boerwinkle E; de Bakker PI; Kivimaki M; Asselbergs FW; Sattar N; Lawlor DA; Whittaker J; Davey Smith G; Mukamal K; Psaty BM; Wilson JG; Lange LA; Hamidovic A; Hingorani AD; Nordestgaard BG; Bobak M; Leon DA; Langenberg C; Palmer TM; Reiner AP; Keating BJ; Dudbridge F; Casas JP;
BMJ; 2014 Jul; 349():g4164. PubMed ID: 25011450
[TBL] [Abstract][Full Text] [Related]
11. Alcohol Metabolism in the Progression of Human Nonalcoholic Steatohepatitis.
Li H; Toth E; Cherrington NJ
Toxicol Sci; 2018 Aug; 164(2):428-438. PubMed ID: 29718361
[TBL] [Abstract][Full Text] [Related]
12. Alcohol-metabolizing genes and alcohol phenotypes in an Israeli household sample.
Meyers JL; Shmulewitz D; Aharonovich E; Waxman R; Frisch A; Weizman A; Spivak B; Edenberg HJ; Gelernter J; Hasin DS
Alcohol Clin Exp Res; 2013 Nov; 37(11):1872-81. PubMed ID: 23895337
[TBL] [Abstract][Full Text] [Related]
13. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.
Pan Q; Zhang RN; Wang YQ; Zheng RD; Mi YQ; Liu WB; Shen F; Chen GY; Lu JF; Zhu CY; Zhang SY; Chen YM; Sun WL; Fan JG
World J Gastroenterol; 2015 Jul; 21(28):8605-14. PubMed ID: 26229402
[TBL] [Abstract][Full Text] [Related]
14. Ethnicity and nonalcoholic fatty liver disease.
Bambha K; Belt P; Abraham M; Wilson LA; Pabst M; Ferrell L; Unalp-Arida A; Bass N;
Hepatology; 2012 Mar; 55(3):769-80. PubMed ID: 21987488
[TBL] [Abstract][Full Text] [Related]
15. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphisms of Alcohol Metabolizing Enzymes and Alcohol Consumption are Associated With Asymptomatic Cardiac Remodeling and Subclinical Systolic Dysfunction in Large Community-Dwelling Asians.
Hung CL; Chang SC; Chang SH; Chi PC; Lai YJ; Wang SW; Wu YJ; Yeh HI; Lin SJ; Chen CH; Mochly-Rosen D; Wang LY;
Alcohol Alcohol; 2017 Nov; 52(6):638-646. PubMed ID: 29016726
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations of aldehyde dehydrogenase 2 and alcohol dehydrogenase 1B are associated with the etiology of atrial fibrillation in Japanese.
Nakano Y; Ochi H; Onohara Y; Sairaku A; Tokuyama T; Matsumura H; Tomomori S; Amioka M; Hironomobe N; Motoda C; Oda N; Chayama K; Chen CH; Gross ER; Mochly-Rosen D; Kihara Y
J Biomed Sci; 2016 Dec; 23(1):89. PubMed ID: 27927211
[TBL] [Abstract][Full Text] [Related]
18. Alcohol consumption mediates the relationship between ADH1B and DSM-IV alcohol use disorder and criteria.
Kilcoyne B; Shmulewitz D; Meyers JL; Aharonovich E; Greenstein E; Frisch A; Weizman A; Spivak B; Edenberg HJ; Gelernter J; Hasin DS
J Stud Alcohol Drugs; 2014 Jul; 75(4):635-42. PubMed ID: 24988262
[TBL] [Abstract][Full Text] [Related]
19. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
[TBL] [Abstract][Full Text] [Related]
20. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
Kistler KD; Brunt EM; Clark JM; Diehl AM; Sallis JF; Schwimmer JB;
Am J Gastroenterol; 2011 Mar; 106(3):460-8; quiz 469. PubMed ID: 21206486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
